[1]
C. Ucciferri, A. Auricchio, J. Vecchiet, and K. Falasca, “Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation: Pidotimod in SARS-CoV-2 vaccination”, Mediterr J Hematol Infect Dis, vol. 14, no. 1, p. e2022023, Feb. 2022.